Efficacy and Safety of Azithromycin in the Treatment of Sexually Transmitted Diseases

Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):159-162

Type
Journal article

Abstract

This paper considers safety issues associated with medical therapy of sexually transmitted diseases (STDs). Data supporting safety of azithromycin as part of treatment regimens for infections due to chlamydia and mycoplasma are provided. Possible triggers of drug-induced liver injury when administering antimicrobial therapy of STDs are also discussed.

Views
0 Abstract
0 PDF
0 BibTeX
Shared
0
0
0
0
0
0